Secukinumab shows Higher Symptomatic improvement Versus Etanercept in Psoriatic Arthritis- Comparative Effectiveness Up To 24 Weeks Assessed by Matching-Adjusted Indirect Comparison
Abstract
Authors
P Mease E Choy H Thom C Kalyvas N Lopes L Pricop K Gandhi SM Jugl P Nash